# Cocrystal Pharma, Inc.: Form SCHEDULE 13D/A, filed Oct 2, 2025

- Company: [Cocrystal Pharma, Inc.](/companies/cocp.md) (CIK 1412486)
- Form: SCHEDULE 13D/A
- Filed: 2025-10-02
- Accepted by EDGAR: Oct 2, 2025, 18:29 ET
- Period: not reported
- Accession: 0001493152-25-016751
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1412486/000149315225016751/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1412486/000149315225016751/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1412486/000149315225016751/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Oct 2, 2025.
Source: SEC EDGAR, the filing index for accession 0001493152-25-016751. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.